Ten Feizi

Ten Feizi

Auto-generated profile, based on publicly available information

Ten Feizi

Glycosciences Laboratory, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK

Research Focus & Metrics

Academic Career Length

63Years (1964-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1994 in Cell
Verified
Journal Article
Closed access
SBSamuel H. Barondes
Samuel H. Barondes
VCVincent Castronovo
Vincent Castronovo
DCDouglas N.W. Cooper
Douglas N.W. Cooper
RCRichard D. Cummings
Richard D. Cummings
KDKurt Drickamer
Kurt Drickamer
JWJohn L. Wang
John L. Wang


25 November 2011 in Science
Verified
Journal Article
Closed access
PDF file
RPRobert Pejchal
Robert Pejchal
KDKatie J. Doores
Katie J. Doores
LWLaura M. Walker
Laura M. Walker
RKReza Khayat
Reza Khayat
PHPo-Ssu Huang
Po-Ssu Huang
IWIan A. Wilson
Ian A. Wilson
The HIV envelope (Env) protein gp120 is protected from antibody recognition by a dense glycan shield. However, several of the recently identified PGT broadly neutralizing antibodies appear to interact directly with the HIV glycan coat. Crystal structures of antigen-binding fragments (Fabs) PGT 127 and 128 with Man9 at 1.65 and 1.29 angstrom resolution, respectively, and glycan binding data delineate a specific high mannose-binding site. Fab PGT 128 complexed with a fully glycosylated gp120 outer domain at 3.25 angstroms reveals that the antibody penetrates the glycan shield and recognizes two conserved glycans as well as a short β-strand segment of the gp120 V3 loop, accounting for its high binding affinity and broad specificify. Furthermore, our data suggest that the high neutralization potency of PGT 127 and 128 immunoglobulin Gs may be mediated by cross-linking Env trimers on the viral surface.

30 October 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HMHugo Mouquet
Hugo Mouquet
LSLouise Scharf
Louise Scharf
ZEZelda Euler
Zelda Euler
YLYan Liu
Yan Liu
CECaroline Eden
Caroline Eden
Pamela J BjorkmanPamela J Bjorkman
Pamela J Bjorkman
Broadly neutralizing HIV antibodies (bNAbs) can recognize carbohydrate-dependent epitopes on gp120. In contrast to previously characterized glycan-dependent bNAbs that recognize high-mannose N -glycans, PGT121 binds complex-type N -glycans in glycan microarrays. We isolated the B-cell clone encoding PGT121, which segregates into PGT121-like and 10-1074–like groups distinguished by sequence, binding affinity, carbohydrate recognition, and neutralizing activity. Group 10-1074 exhibits remarkable potency and breadth but no detectable binding to protein-free glycans. Crystal structures of unliganded PGT121, 10-1074, and their likely germ-line precursor reveal that differential carbohydrate recognition maps to a cleft between complementarity determining region (CDR)H2 and CDRH3. This cleft was occupied by a complex-type N -glycan in a “liganded” PGT121 structure. Swapping glycan contact residues between PGT121 and 10-1074 confirmed their importance for neutralization. Although PGT121 binds complex-type N -glycans, PGT121 recognized high-mannose-only HIV envelopes in isolation and on virions. As HIV envelopes exhibit varying proportions of high-mannose- and complex-type N -glycans, these results suggest promiscuous carbohydrate interactions, an advantageous adaptation ensuring neutralization of all viruses within a given strain.

1 July 1981 in Nature
Verified
Journal Article
Open access
PDF file
HGH. C. Gooi
H. C. Gooi
TFT. Feizi
T. Feizi
AKA. Kapadia
A. Kapadia
BKB. B. Knowles
B. B. Knowles
DSD. Solter
D. Solter
MEM. J. Evans
M. J. Evans
There is much interest in developmentally regulated molecules which may have function in cell interactions and sorting during embryogenesis and differentiation. Numerous antisera have been raised which detect antigens that are expressed in early embryonic cells and become restricted during differentiation, being expressed in only a minority of adult cells (reviewed in refs 1–3). The precise antigenic determinants recognized by such antisera have not been defined. However, studies using a hybri-doma antibody against mouse spleen cells4 and monoclonal autoantibodies of patients with cold agglutinin disease5 have shown that two defined carbohydrate antigen systems, the Forssman and the li antigens, have stage-specific expression in early mouse embryos. We now describe evidence that the stage-specific embryonic antigen SSEA-1 (ref. 6) involves the carbohydrate sequence Galβ1 → 4GlcNAc ↑1,3 Fucα This determinant is formed by α 1 → 3 fucosylation of blood group I or i antigens which are branched or linear oligosaccharides, respectively7–9, built of Galβ1 →4GlcNAc units and known as type 2 precursor chains10 of the major blood group antigens. Thus, we introduce the concept of simple glycosylation changes as a basis for stage-specific expression of embryonic antigens.

3 September 2002 in Nature Biotechnology
Verified
Journal Article
Closed access
SFShigeyuki Fukui
Shigeyuki Fukui
TFTen Feizi
Ten Feizi
CGChristine Galustian
Christine Galustian
ALAlexander M. Lawson
Alexander M. Lawson
WCWengang Chai
Wengang Chai